0001628280-21-021009.txt : 20211101
0001628280-21-021009.hdr.sgml : 20211101
20211101164858
ACCESSION NUMBER: 0001628280-21-021009
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211029
FILED AS OF DATE: 20211101
DATE AS OF CHANGE: 20211101
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Koenig Sheldon L.
CENTRAL INDEX KEY: 0001766524
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35986
FILM NUMBER: 211367886
MAIL ADDRESS:
STREET 1: C/O PORTOLA PHARMACEUTICALS, INC.
STREET 2: 270 EAST GRAND AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Esperion Therapeutics, Inc.
CENTRAL INDEX KEY: 0001434868
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3891 RANCHERO DRIVE, SUITE 150
CITY: ANN ARBOR
STATE: MI
ZIP: 48108
BUSINESS PHONE: 734-887-3903
MAIL ADDRESS:
STREET 1: 3891 RANCHERO DRIVE, SUITE 150
CITY: ANN ARBOR
STATE: MI
ZIP: 48108
FORMER COMPANY:
FORMER CONFORMED NAME: HDL THERAPEUTICS INC
DATE OF NAME CHANGE: 20080513
4
1
wf-form4_163579971447247.xml
FORM 4
X0306
4
2021-10-29
0
0001434868
Esperion Therapeutics, Inc.
ESPR
0001766524
Koenig Sheldon L.
C/O ESPERION THERAPEUTICS, INC.
3891 RANCHERO DRIVE, SUITE 150
ANN ARBOR
MI
48108
1
1
0
0
President and CEO
Common Stock
2021-10-29
4
A
0
26700
0
A
76700
D
Stock Option (right to buy)
8.94
2031-10-29
Common Stock
37850.0
37850
D
The awards will vest as follows: 50% shall vest upon CVOT public presentation of results; and 50% shall vest upon obtaining approval for cardiovascular risk reduction into the U.S. label.
/s/ Richard B. Bartram, by power of attorney
2021-11-01